India launches doctor-led AI healthcare platform: Key details inside
By combining wearable biosensors, predictive AI, and round-the-clock doctor supervision, iLive Connect is redefining patient safety in India, shifting healthcare from reactive treatment to preventive, continuous medical care beyond hospital walls.
India has taken a decisive step towards preventive and continuous healthcare with the launch of iLive Connect, a doctor-led, AI-enabled healthcare ecosystem that promises to monitor patients round the clock, far beyond hospital walls. Designed to detect early signs of medical deterioration and reduce avoidable hospitalisations, the platform combines wearable biosensors, predictive analytics, and real-time clinical supervision.
In an exclusive interaction, Dr Rahul Chandola, cardiovascular and thoracic surgeon and Founder of iLive Connect, along with Dr Viveka Kumar, senior interventional cardiologist and Co-founder, explained how the system bridges one of healthcare’s biggest gaps: the absence of continuous medical oversight once a patient returns home.
A SHIFT FROM EPISODIC TO CONTINUOUS CARE
“Most life-threatening events do not happen inside hospitals; they happen at home, when patients are medically unsupervised,” Dr Chandola said. “iLive Connect was developed to ensure that patients remain under medical observation even after discharge, without disrupting their daily lives.”
At the heart of the platform is a lightweight biosensor patch paired with a wristband. Together, they continuously record and transmit health data to a central command centre manned by specialised doctors, 247.
VITAL PARAMETERS MONITORED
According to Dr Chandola, the device captures hospital-grade physiological data, including:
- Two-lead ECG
- Heart rate and heart rate variability
- Respiratory rate
- Oxygen saturation (SpO)
- Body temperature
- Blood pressure trends
- Physical activity and posture
- Sleep metrics, fatigue levels, and fall detection
“This is not consumer wellness tracking. These are clinical parameters that allow doctors to identify deterioration hours or even days before symptoms appear,” he said.
ACCURACY AND CLINICAL VALIDATION
On accuracy, Dr Viveka Kumar was clear: “The biosensor and wristband are FDA-approved and CE-certified devices. The data quality is comparable to hospital monitoring systems. What makes the difference is not just accuracy, but continuous data flow interpreted by trained doctors and AI algorithms.”
He added that AI helps identify subtle trends, such as rising heart rate variability or gradual oxygen desaturation, that single readings often miss.
THE IDEA BEHIND iLIVE CONNECT
The concept was born from a recurring clinical reality. “Patients come to hospitals when their condition has already worsened because they didn’t realise something was wrong,” Dr Chandola explained. “We wanted to reverse that timeline, detect problems early, intervene early, and prevent emergencies altogether.”
WHAT MAKES IT A GLOBAL FIRST
Unlike most wearable technologies that merely display data to users, iLive Connect is doctor-led. “Technology does not replace doctors here; it empowers them,” Dr Kumar said. “Doctors monitor patients in real time, call them proactively, adjust treatment, send digital prescriptions, and even trigger emergency responses when required. That integrated clinical ecosystem is what makes this a global first.”
WATERPROOF AND DESIGNED FOR DAILY LIFE
Since the device is worn continuously, usability was critical. “Yes, it is waterproof and designed to be worn during bathing and daily activities,” Dr Chandola confirmed. “Patients often forget they are wearing it, which is exactly what we wanted.”
Location tracking and emergency logistics are built into the platform. “If vitals cross dangerous thresholds, say heart rate above 150 or critically abnormal blood pressure, the command centre initiates immediate action,” said Dr Kumar. “Ambulance services are integrated, and patients are taken to the nearest capable hospital within 15–20 minutes.”
COST AND ACCESSIBILITY
While exact pricing varies based on care plans, the founders emphasised affordability. “When you compare it to the cost of repeat hospitalisations or ICU admissions, this is significantly more cost-effective,” Dr Chandola said. The platform is especially targeted at seniors living alone, chronic disease patients, and recently discharged individuals.
EASE OF USE FOR ELDERLY PATIENTS
Addressing concerns about older patients adapting to AI-based systems, Dr Kumar noted, “The patient doesn’t need to operate AI. They simply wear the device. Doctors do the rest. Even patients in their 70s and 80s use it comfortably.”
In a 10-week observational study involving over 410 patients, iLive Connect reported a 76 per cent reduction in repeat hospitalisations. “That outcome alone validates the model,” Dr Chandola said. “Preventive care is no longer theoretical, it’s measurable.”
India has taken a decisive step towards preventive and continuous healthcare with the launch of iLive Connect, a doctor-led, AI-enabled healthcare ecosystem that promises to monitor patients round the clock, far beyond hospital walls. Designed to detect early signs of medical deterioration and reduce avoidable hospitalisations, the platform combines wearable biosensors, predictive analytics, and real-time clinical supervision.
In an exclusive interaction, Dr Rahul Chandola, cardiovascular and thoracic surgeon and Founder of iLive Connect, along with Dr Viveka Kumar, senior interventional cardiologist and Co-founder, explained how the system bridges one of healthcare’s biggest gaps: the absence of continuous medical oversight once a patient returns home.
A SHIFT FROM EPISODIC TO CONTINUOUS CARE
“Most life-threatening events do not happen inside hospitals; they happen at home, when patients are medically unsupervised,” Dr Chandola said. “iLive Connect was developed to ensure that patients remain under medical observation even after discharge, without disrupting their daily lives.”
At the heart of the platform is a lightweight biosensor patch paired with a wristband. Together, they continuously record and transmit health data to a central command centre manned by specialised doctors, 247.
VITAL PARAMETERS MONITORED
According to Dr Chandola, the device captures hospital-grade physiological data, including:
- Two-lead ECG
- Heart rate and heart rate variability
- Respiratory rate
- Oxygen saturation (SpO)
- Body temperature
- Blood pressure trends
- Physical activity and posture
- Sleep metrics, fatigue levels, and fall detection
“This is not consumer wellness tracking. These are clinical parameters that allow doctors to identify deterioration hours or even days before symptoms appear,” he said.
ACCURACY AND CLINICAL VALIDATION
On accuracy, Dr Viveka Kumar was clear: “The biosensor and wristband are FDA-approved and CE-certified devices. The data quality is comparable to hospital monitoring systems. What makes the difference is not just accuracy, but continuous data flow interpreted by trained doctors and AI algorithms.”
He added that AI helps identify subtle trends, such as rising heart rate variability or gradual oxygen desaturation, that single readings often miss.
THE IDEA BEHIND iLIVE CONNECT
The concept was born from a recurring clinical reality. “Patients come to hospitals when their condition has already worsened because they didn’t realise something was wrong,” Dr Chandola explained. “We wanted to reverse that timeline, detect problems early, intervene early, and prevent emergencies altogether.”
WHAT MAKES IT A GLOBAL FIRST
Unlike most wearable technologies that merely display data to users, iLive Connect is doctor-led. “Technology does not replace doctors here; it empowers them,” Dr Kumar said. “Doctors monitor patients in real time, call them proactively, adjust treatment, send digital prescriptions, and even trigger emergency responses when required. That integrated clinical ecosystem is what makes this a global first.”
WATERPROOF AND DESIGNED FOR DAILY LIFE
Since the device is worn continuously, usability was critical. “Yes, it is waterproof and designed to be worn during bathing and daily activities,” Dr Chandola confirmed. “Patients often forget they are wearing it, which is exactly what we wanted.”
Location tracking and emergency logistics are built into the platform. “If vitals cross dangerous thresholds, say heart rate above 150 or critically abnormal blood pressure, the command centre initiates immediate action,” said Dr Kumar. “Ambulance services are integrated, and patients are taken to the nearest capable hospital within 15–20 minutes.”
COST AND ACCESSIBILITY
While exact pricing varies based on care plans, the founders emphasised affordability. “When you compare it to the cost of repeat hospitalisations or ICU admissions, this is significantly more cost-effective,” Dr Chandola said. The platform is especially targeted at seniors living alone, chronic disease patients, and recently discharged individuals.
EASE OF USE FOR ELDERLY PATIENTS
Addressing concerns about older patients adapting to AI-based systems, Dr Kumar noted, “The patient doesn’t need to operate AI. They simply wear the device. Doctors do the rest. Even patients in their 70s and 80s use it comfortably.”
In a 10-week observational study involving over 410 patients, iLive Connect reported a 76 per cent reduction in repeat hospitalisations. “That outcome alone validates the model,” Dr Chandola said. “Preventive care is no longer theoretical, it’s measurable.”